Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04312542 · ClinicalTrials.gov registry record
Systemic Markers of Inflammation: 9- and 12-Month Follow-Up Post Non-Surgical Periodontal Therapy
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 60
- Enrollment target
NCT04312542 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 60 participants.
The verdict
NCT04312542 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The primary goal of this study is to determine the amount of three systemic markers of inflammation: 1) Hemoglobin A1c (Hgb A1c, 2) High Sensitivity C-Reactive Protein (hsCRP), and 3) Haptoglobin (Hp) at 9 and 12 month follow-up post scaling and rootplaning (SRP) with and without minocycline HCl microspheres, 1 mg.
Interventions
- PROCEDURE Measurement of Biomarkers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-07-21 |
| Est. Completion | 2022-08-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04312542
The ClinicalTrials.gov registry entry for NCT04312542 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Measurement of Biomarkers is the first listed.
NCT04312542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04312542 about?
NCT04312542 is a clinical study titled "Systemic Markers of Inflammation: 9- and 12-Month Follow-Up Post Non-Surgical Periodontal Therapy". The primary goal of this study is to determine the amount of three systemic markers of inflammation: 1) Hemoglobin A1c (Hgb A1c, 2) High Sensitivity C-Reactive Protein (hsCRP), and 3) Haptoglobin (Hp) at 9 and 12 month follow-up post scaling and rootplaning (SRP) with and without minocycline HCl mic...
What is the current status of trial NCT04312542?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2020-07-21. Estimated completion is 2022-08-16.
What interventions are being tested in trial NCT04312542?
The interventions under investigation include: Measurement of Biomarkers (PROCEDURE).
Who is sponsoring clinical trial NCT04312542?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.